Barrier Therapeutics Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 24.1 | 6.7 | 2.5 |
| Cost of Goods Sold | 3.2 | 1.4 | 0.5 |
| Gross Profit | 20.9 | 5.3 | 2.0 |
| Gross Profit Margin | 86.8% | 78.8% | 78.7% |
| SG&A Expense | 76.8 | 60.8 | 49.0 |
| Depreciation & Amortization | 0.8 | 0.9 | 1.6 |
| Operating Income | (56.6) | (56.4) | (48.7) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 2.1 | 3.0 | 2.9 |
| Nonoperating Expenses | 0.2 | 0.1 | 0.1 |
| Income Before Taxes | (54.7) | (53.4) | (45.8) |
| Income Taxes | (1.0) | (0.7) | (0.5) |
| Net Income After Taxes | (53.7) | (52.8) | (45.2) |
| Continuing Operations | (53.7) | (52.8) | (45.2) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (53.7) | (52.8) | (45.2) |
| Total Net Income | (53.7) | (52.7) | (45.2) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (1.74) | (2.06) | (1.91) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
